Discontinuation report TEVA-SUCRALFATE
| Report ID | 266359 |
| Drug Identification Number | 02045702 |
| Brand name | TEVA-SUCRALFATE |
| Common or Proper name | SUCRALFATE 1GM |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | SUCRALFATE |
| Strength(s) | 1G |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | ALL (100's and 500's) |
| ATC code | A02BX |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2025-08-28 |
| Actual discontinuation date | 2025-08-28 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-09-02 | French | Compare |
| v1 | 2025-09-02 | English | Compare |
Showing 1 to 2 of 2